Valproate Pregnancy Prevention Programme: temporary advice for management during coronavirus (COVID-19) , MHRA

Owing to the COVID-19 pandemic and the reduced potential for face to face clinic appointments due to sheilding, the MHRA has made some temporary amendments to the pregnancy prevention programme for valproate products.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news